Show simple item record

dc.contributor.authorFitzgerald, Rebecca
dc.contributor.authorReid, Brian J
dc.date.accessioned2018-09-11T17:32:12Z
dc.date.available2018-09-11T17:32:12Z
dc.date.issued2017-11
dc.identifier.issn2352-345X
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/280194
dc.description.abstractIn the Perspective article in the March issue of Cellular and Molecular Gastroenterology and Hepatology,1 the Cytosponge erroneously was cited during the publication process as a Medtronic device (Medtronic, Minneapolis, MN). We would like to clarify that all published studies on Cytosponge to date have been performed using a research design patented by the Medical Research Council UK and made by local manufacturers and performed under permission from the Medical Health Regulatory Agency of the United Kingdom. This prototype device currently is being used in a 9000-patient primary care study in the United Kingdom (Barrett's ESophagus Trial 3 [BEST3]; trial ID ISRCTN68382401). This important study takes major steps to improve care for patients with Barrett’s esophagus.
dc.format.mediumElectronic-eCollection
dc.languageeng
dc.publisherElsevier BV
dc.titleEarly Diagnosis of Gastroesophageal Cancers and the Cytosponge: A Work in Progress.
dc.typeArticle
prism.issueIdentifier3
prism.publicationDate2017
prism.publicationNameCell Mol Gastroenterol Hepatol
prism.startingPage447
prism.volume4
dc.identifier.doi10.17863/CAM.27561
dcterms.dateAccepted2017-08-11
rioxxterms.versionofrecord10.1016/j.jcmgh.2017.07.004
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2017-11
dc.contributor.orcidFitzgerald, Rebecca [0000-0002-3434-3568]
dc.identifier.eissn2352-345X
rioxxterms.typeJournal Article/Review
pubs.funder-project-idMedical Research Council (MC_UU_12022/2)
cam.issuedOnline2017-08-14
rioxxterms.freetoread.startdate2018-11-30


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record